The ROCK inhibitor, thiazovivin, inhibits human corneal endothelial‑to‑mesenchymal transition/epithelial‑to‑mesenchymal transition and increases ionic transporter expression

Wu,Qianni; Ouyang,Chen; Xie,Lijie; Ling,Yunzhi; Huang,Ting

doi:10.3892/ijmm.2017.3103

The ROCK inhibitor, thiazovivin, inhibits human corneal endothelial‑to‑mesenchymal transition/epithelial‑to‑mesenchymal transition and increases ionic transporter expression

Authors:
- Qianni Wu
- Chen Ouyang
- Lijie Xie
- Yunzhi Ling
- Ting Huang
View Affiliations

Affiliations: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat‑sen University, Guangzhou, Guangdong 510060, P.R. China
Published online on: August 18, 2017 https://doi.org/10.3892/ijmm.2017.3103
Pages: 1009-1018
Copyright: © Wu et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Corneal diseases exhibit a high prevalence and are prone to cause blindness; furthermore, maintaining the morphology and ionic transporter expression in corneal endothelial cells (CECs) is crucial for treatment of these diseases. This study aimed to investigate the effects of the novel Rho associated coiled-coil containing protein kinase (ROCK) inhibitor, thiazovivin (2,4‑disubstituted thiazole, TZV), on human corneal endothelial‑to‑mesenchymal transition/epithelial‑to‑mesenchymal transition (EndMT/EMT), cell morphology, junction proteins and ionic transporter expression in human CECs (HCECs) in vitro and then to clarify the mechanisms of action of TZV. In the present study, primary HCECs were cultured in vitro and passaged. The expression levels of adhesion proteins (E‑cadherin and N‑cadherin), the EndMT/EMT marker, α smooth muscle actin (α‑SMA), the tight junction protein, Zonula occludens-1 (ZO‑1), and the ionic transporter, Na+/K+‑ATPase, were detected by immunofluorescence. The proliferative ability of the HCECs was determined by CCK-8 assay. The mRNA expression of the EndMT/EMT‑inducing gene, Snail, was examined by RT‑PCR. The protein expression levels of ROCK1/2 were evaluated by western blot analysis. The HCECs were cultured with TZV at various concentrations (2, 4, or 6 µM) for different periods of time (24 or 48 h). We found that the the cell states of the HCECs co‑cultured with 4 µM TZV for 48 h reached the optimum, and corneal EndMT/EMT was inhibited, as evidenced by the significantly upregulated expression of ZO‑1 and E‑cadherin, and the markedly downregulated expression of N‑cadherin and α‑SMA. Furthermore, the cells exhibited a normal, tightly connected hexagonal or pentagonal morphology. Additionally, the protein expression of ROCK1/2 and the mRNA expression of Snail were significantly decreased. However, there was no significant difference between the TZV‑treated and the control groups as regards HCEC proliferative ability. These findings suggested that the ROCK inhibitor, TZV (4 µM), was effective in improving the morphology, cell junctions and ionic transporter expression of HCECs by inhibiting EndMT/EMT, but had no effect on HCEC proliferation.

View Figures

View References

1	Mishima S: Clinical investigations on the corneal endothelium-XXXVIII Edward Jackson Memorial Lecture. Am J Ophthalmol. 93:1–29. 1982. View Article : Google Scholar : PubMed/NCBI
2	Wulle KG: Electron microscopy of the fetal development of the corneal endothelium and Descemet's membrane of the human eye. Invest Ophthalmol. 11:897–904. 1972.PubMed/NCBI
3	Laing RA, Sanstrom MM, Berrospi AR and Leibowitz HM: Changes in the corneal endothelium as a function of age. Exp Eye Res. 22:587–594. 1976. View Article : Google Scholar : PubMed/NCBI
4	Singh JS, Haroldson TA and Patel SP: Characteristics of the low density corneal endothelial monolayer. Exp Eye Res. 115:239–245. 2013. View Article : Google Scholar : PubMed/NCBI
5	He Z, Campolmi N, Gain P, Ha Thi BM, Dumollard JM, Duband S, Peoc'h M, Piselli S, Garraud O and Thuret G: Revisited microanatomy of the corneal endothelial periphery: New evidence for continuous centripetal migration of endothelial cells in humans. Stem Cells. 30:2523–2534. 2012. View Article : Google Scholar : PubMed/NCBI
6	Matsuda M, Sawa M, Edelhauser HF, Bartels SP, Neufeld AH and Kenyon KR: Cellular migration and morphology in corneal endothelial wound repair. Invest Ophthalmol Vis Sci. 26:443–449. 1985.PubMed/NCBI
7	Edelhauser HF: The resiliency of the corneal endothelium to refractive and intraocular surgery. Cornea. 19:263–273. 2000. View Article : Google Scholar : PubMed/NCBI
8	Tan DTH, Dart JKG, Holland EJ and Kinoshita S: Corneal transplantation. Lancet. 379:1749–1761. 2012. View Article : Google Scholar : PubMed/NCBI
9	Hirata-Tominaga K, Nakamura T, Okumura N, Kawasaki S, Kay EP, Barrandon Y, Koizumi N and Kinoshita S: Corneal endothelial cell fate is maintained by LGR5 through the regulation of hedgehog and Wnt pathway. Stem Cells. 31:1396–1407. 2013. View Article : Google Scholar : PubMed/NCBI
10	Peh GS, Toh KP, Wu FY, Tan DT and Mehta JS: Cultivation of human corneal endothelial cells isolated from paired donor corneas. PLoS One. 6:e283102011. View Article : Google Scholar : PubMed/NCBI
11	Okumura N, Kay EP, Nakahara M, Hamuro J, Kinoshita S and Koizumi N: Inhibition of TGF-β signaling enables human corneal endothelial cell expansion in vitro for use in regenerative medicine. PLoS One. 8:e580002013. View Article : Google Scholar
12	Engelmann K and Friedl P: Optimization of culture conditions for human corneal endothelial cells. In Vitro Cell Dev Biol. 25:1065–1072. 1989. View Article : Google Scholar : PubMed/NCBI
13	Zhu C and Joyce NC: Proliferative response of corneal endothelial cells from young and older donors. Invest Ophthalmol Vis Sci. 45:1743–1751. 2004. View Article : Google Scholar : PubMed/NCBI
14	Engelmann K, Bednarz J and Valtink M: Prospects for endothelial transplantation. Exp Eye Res. 78:573–578. 2004. View Article : Google Scholar : PubMed/NCBI
15	McNiven MA: Breaking away: Matrix remodeling from the leading edge. Trends Cell Biol. 23:16–21. 2013. View Article : Google Scholar
16	Roy O, Leclerc VB, Bourget JM, Thériault M and Proulx S: Understanding the process of corneal endothelial morphological change in vitro. Invest Ophthalmol Vis Sci. 56:1228–1237. 2015. View Article : Google Scholar : PubMed/NCBI
17	Lee JG, Ko MK and Kay EP: Endothelial mesenchymal transformation mediated by IL-1β-induced FGF-2 in corneal endothelial cells. Exp Eye Res. 95:35–39. 2012. View Article : Google Scholar
18	Pipparelli A, Arsenijevic Y, Thuret G, Gain P, Nicolas M and Majo F: ROCK inhibitor enhances adhesion and wound healing of human corneal endothelial cells. PLoS One. 8:e620952013. View Article : Google Scholar : PubMed/NCBI
19	Gu L, Gao Q, Ni L, Wang M and Shen F: Fasudil inhibits epithelial-myofibroblast transdifferentiation of human renal tubular epithelial HK-2 cells induced by high glucose. Chem Pharm Bull. 61:688–694. 2013. View Article : Google Scholar : PubMed/NCBI
20	Park S, Kim D, Jung YG and Roh S: Thiazovivin, a Rho kinase inhibitor, improves stemness maintenance of embryo-derived stem-like cells under chemically defined culture conditions in cattle. Anim Reprod Sci. 161:47–57. 2015. View Article : Google Scholar : PubMed/NCBI
21	Yang H, Liu Z, Ma Y, Zhong C, Yin Q, Zhou C, Shi L, Cai Y, Zhao H, Wang H, et al: Generation of haploid embryonic stem cells from Macaca fascicularis monkey parthenotes. Cell Res. 23:1187–1200. 2013. View Article : Google Scholar : PubMed/NCBI
22	Tanaka T, Nishimura D, Wu RC, Amano M, Iso T, Kedes L, Nishida H, Kaibuchi K and Hamamori Y: Nuclear Rho kinase, ROCK2, targets p300 acetyltransferase. J Biol Chem. 281:15320–15329. 2006. View Article : Google Scholar : PubMed/NCBI
23	Lamouille S, Xu J and Derynck R: Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol. 15:178–196. 2014. View Article : Google Scholar : PubMed/NCBI
24	Huang RY, Guilford P and Thiery JP: Early events in cell adhesion and polarity during epithelial-mesenchymal transition. J Cell Sci. 125:4417–4422. 2012. View Article : Google Scholar : PubMed/NCBI
25	Kaibuchi K, Kuroda S and Amano M: Regulation of the cytoskeleton and cell adhesion by the Rho family GTPases in mammalian cells. Annu Rev Biochem. 68:459–486. 1999. View Article : Google Scholar
26	Somlyo AP and Somlyo AV: Signal transduction by G-proteins, rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol. 522:177–185. 2000. View Article : Google Scholar : PubMed/NCBI
27	Leung T, Chen XQ, Manser E and Lim L: The p160 RhoA-binding kinase ROK alpha is a member of a kinase family and is involved in the reorganization of the cytoskeleton. Mol Cell Biol. 16:5313–5327. 1996. View Article : Google Scholar : PubMed/NCBI
28	Tominaga T and Barber DL: Na-H exchange acts downstream of RhoA to regulate integrin-induced cell adhesion and spreading. Mol Biol Cell. 9:2287–2303. 1998. View Article : Google Scholar : PubMed/NCBI
29	Olson MF, Ashworth A and Hall A: An essential role for Rho, Rac, and Cdc42 GTPases in cell cycle progression through G1. Science. 269:1270–1272. 1995. View Article : Google Scholar : PubMed/NCBI
30	Zhang L, Valdez JM, Zhang B, Wei L, Chang J and Xin L: ROCK inhibitor Y-27632 suppresses dissociation-induced apoptosis of murine prostate stem/progenitor cells and increases their cloning efficiency. PLoS One. 6:e182712011. View Article : Google Scholar : PubMed/NCBI
31	Olson MF: Applications for ROCK kinase inhibition. Curr Opin Cell Biol. 20:242–248. 2008. View Article : Google Scholar : PubMed/NCBI
32	Liao JK, Seto M and Noma K: Rho kinase (ROCK) inhibitors. J Cardiovasc Pharmacol. 50:17–24. 2007. View Article : Google Scholar : PubMed/NCBI
33	Okumura N, Ueno M, Koizumi N, Sakamoto Y, Hirata K, Hamuro J and Kinoshita S: Enhancement on primate corneal endothelial cell survival in vitro by a ROCK inhibitor. Invest Ophthalmol Vis Sci. 50:3680–3687. 2009. View Article : Google Scholar : PubMed/NCBI
34	Okumura N, Koizumi N, Ueno M, Sakamoto Y, Takahashi H, Hirata K, Torii R, Hamuro J and Kinoshita S: Enhancement of corneal endothelium wound healing by Rho-associated kinase (ROCK) inhibitor eye drops. Br J Ophthalmol. 95:1006–1009. 2011. View Article : Google Scholar : PubMed/NCBI
35	Okumura N, Koizumi N, Kay EP, Ueno M, Sakamoto Y, Nakamura S, Hamuro J and Kinoshita S: The ROCK inhibitor eye drop accelerates corneal endothelium wound healing. Invest Ophthalmol Vis Sci. 54:2493–2502. 2013. View Article : Google Scholar : PubMed/NCBI
36	Tokushige H, Inatani M, Nemoto S, Sakaki H, Katayama K, Uehata M and Tanihara H: Effects of topical administration of y-39983, a selective rho-associated protein kinase inhibitor, on ocular tissues in rabbits and monkeys. Invest Ophthalmol Vis Sci. 48:3216–3222. 2007. View Article : Google Scholar : PubMed/NCBI
37	Yilmaz M and Christofori G: EMT, the cytoskeleton, and cancer cell invasion. Cancer Metastasis Rev. 28:15–33. 2009. View Article : Google Scholar : PubMed/NCBI
38	Piera-Velazquez S and Jimenez SA: Molecular mechanisms of endothelial to mesenchymal cell transition (EndoMT) in experimentally induced fibrotic diseases. Fibrogenesis Tissue Repair. 5(Suppl 1): S72012.PubMed/NCBI